Pioneering research by mood disorder experts at Newcastle University has questioned the effectiveness of metyrapone, a drug suggested to treat depression. “Our research has shown that in the population of depressed patients studied, metyraphone is inadequate and therefore should not be routinely recommended as an option for treatment resistant depression,” the study author said in a press release.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.